Qianfoshan Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Qianfoshan Hospital
RECRUITINGPhase 3NCT06043973
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance
To evaluate the efficacy and safety of almonertinib plus anlotinib as first-line treatment for advanced non-small cell lung cancer with EGFR sensitive mutation and TP53 mutation....
Sponsor: Qianfoshan HospitalEnrolling: 981 location
Advanced Non-small Cell Lung Cancer
RECRUITINGNCT06753981
Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world,...
This study is a multicenter, prospective, observational study aimed at investigating the efficacy and safety of triple targeted drug therapy in patients with arterial pulmonary...
Sponsor: Qianfoshan HospitalEnrolling: 481 location
Arterial Pulmonary Hypertension (PAH)
RECRUITINGNCT05407792
Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
The main purpose of this study is to investigate whether long-term oral administration of Staphylococcus albicans tablets can significantly reduce the number of acute...
Sponsor: Qianfoshan HospitalEnrolling: 1341 location
Bronchiectasis